Literature DB >> 24318859

Response to: 'Detection of antinuclear antibodies: added-value of solid phase assay?' by Bossuyt and Fieuws.

Nancy Agmon-Levin1, Jan Damoiseaux, Yehuda Shoenfeld.   

Abstract

Keywords:  Adult Onset Still's Disease; Amyloidosis; Analgesics

Mesh：

Substances：

Year:  2013        PMID： 24318859     DOI： 10.1136/annrheumdis-2013-204797

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies.

Authors:  O Shovman; N Agmon-Levin; B Gilburd; T Martins; A Petzold; T Matthias; Y Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Current practice in laboratory diagnostics of autoimmune diseases in Croatia. 
Survey of the Working group for laboratory diagnostics of autoimmune diseases of the Croatian Society of Medical Biochemistry and Laboratory Medicine.

Authors:  Andrea Tešija Kuna; Lovorka Đerek; Ana Kozmar; Vedrana Drvar
Journal:  Biochem Med (Zagreb)       Date:  2016-10-15       Impact factor: 2.313

3.  Evaluation of an Automated Screening Assay, Compared to Indirect Immunofluorescence, an Extractable Nuclear Antigen Assay, and a Line Immunoassay in a Large Cohort of Asian Patients with Antinuclear Antibody-Associated Rheumatoid Diseases: A Multicenter Retrospective Study.

Authors:  Seri Jeong; Hyunyong Hwang; Juhye Roh; Jung Eun Shim; Jinmi Kim; Geun-Tae Kim; Hee-Sang Tag; Hyon-Suk Kim
Journal:  J Immunol Res       Date:  2018-05-02       Impact factor: 4.818

4.  Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care.

Authors:  Thomas Y Avery; Mart van de Cruys; Jos Austen; Frans Stals; Jan G M C Damoiseaux
Journal:  J Immunol Res       Date:  2014-03-13       Impact factor: 4.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.